These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1527898)

  • 1. Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats--a comparison study with disopyramide and mexiletine.
    He ZS; Komori S; Tamura K; Hashimoto K
    Jpn Circ J; 1992 Aug; 56(8):861-5. PubMed ID: 1527898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats.
    He ZS; Komori S; Tamura K; Hashimoto K
    Jpn Circ J; 1992 Mar; 56(3):286-91. PubMed ID: 1552655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
    Komori S; Sano S; Li BH; Matsumura K; Naitoh A; Mochizuki S; Ishihara T; Watanabe A; Umetani K; Ijiri H
    Heart Vessels; 1995; 10(1):7-11. PubMed ID: 7537263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.
    Saitoh M; Aye NN; Komori S; Nakazawa T; Hashimoto K
    Mol Cell Biochem; 2000 Feb; 205(1-2):133-40. PubMed ID: 10821431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts.
    Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y
    Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    Manz M; Steinbeck G; Nitsch J; Lüderitz B
    Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrillatory properties of alinidine after coronary artery occlusion in rats.
    Harron DW; Brezina M; Lillie C; Kobinger W
    Eur J Pharmacol; 1985 Apr; 110(3):301-8. PubMed ID: 4007054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
    Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic.
    Vanerio G; Maloney JD
    Cleve Clin J Med; 1992; 59(1):79-86. PubMed ID: 1551218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
    Campbell TJ
    J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.